These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2254463)

  • 1. Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.
    Mittelman A; Chen ZJ; Kageshita T; Yang H; Yamada M; Baskind P; Goldberg N; Puccio C; Ahmed T; Arlin Z
    J Clin Invest; 1990 Dec; 86(6):2136-44. PubMed ID: 2254463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
    Chen ZJ; Yang H; Ferrone S
    J Immunol; 1991 Aug; 147(3):1082-90. PubMed ID: 1861071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human high-molecular-weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody TK7-371.
    Chen ZJ; Yang H; Kageshita T; Ferrone S
    Cancer Res; 1991 Sep; 51(18):4790-7. PubMed ID: 1716513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
    Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
    Yang H; Chen ZJ; Kageshita T; Yamada M; Ferrone S
    Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
    Mittelman A; Chen ZJ; Yang H; Wong GY; Ferrone S
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):466-70. PubMed ID: 1731316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
    Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
    Mittelman A; Wang X; Matsumoto K; Ferrone S
    Hybridoma; 1995 Apr; 14(2):175-81. PubMed ID: 7590776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies.
    Kusama M; Kageshita T; Chen ZJ; Ferrone S
    J Immunol; 1989 Dec; 143(11):3844-52. PubMed ID: 2584721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
    Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
    Wang X; Ko EC; Peng L; Gillies SD; Ferrone S
    Cancer Res; 2005 Aug; 65(15):6976-83. PubMed ID: 16061683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma.
    Ferrone S; Chen ZJ; Liu CC; Hirai S; Kageshita T; Mittelman A
    Pharmacol Ther; 1993; 57(2-3):259-90. PubMed ID: 8361995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of anti-idiotypic monoclonal antibodies in advanced melanoma].
    Kageshita T; Hirai S; Ono T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):163-9. PubMed ID: 8311486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
    Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
    Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
    Ferrone S; Kageshita T; Hirai S
    J Dermatol; 1993 Sep; 20(9):533-9. PubMed ID: 8227707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
    Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
    Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral antimelanoma immunity: induction by mouse antiidiotypic mAb, MK2-23 and association with survival of patients with advanced melanoma.
    Mittelman A; Puccio C; Chun H; Ahmed T
    Mt Sinai J Med; 1992 May; 59(3):234-7. PubMed ID: 1603113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of anti HMW.MAA antibodies in sera of melanoma patients using antiidiotypic monoclonal antibodies].
    Nakamura T; Kageshita T; Arao T; Yamazaki N; Ishihara K
    Nihon Hifuka Gakkai Zasshi; 1990 Oct; 100(11):1121-6. PubMed ID: 2273574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions.
    Kageshita T; Hirai S; Ono T; Ferrone S
    Int J Cancer; 1995 Jan; 60(3):334-40. PubMed ID: 7829240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.